VoltaBack Raises $3.2M in

BioLinker

BioLinker is a biotechnology and synthetic biology startup created by scientists, for scientists. We develop innovative solutions, services, and research kits for academic and industrial applications involving proteins, helping laboratories and companies accelerate research and development with greater practicality, quality, and reliability. Our work is based on cell-free protein synthesis technology (CFPS), a fast and flexible approach for protein expression that enables shorter development cycles and supports a wide range of scientific and industrial applications. By combining experimental expertise in protein science with data-driven and AI-supported approaches, we aim to make protein development faster, more predictable, and more accessible for research and industry. More than a service provider, BioLinker acts as a proactive scientific partner, supporting clients with technical expertise, personalized guidance, and continuous assistance throughout their projects. To learn more about BioLinker, our technologies, products, and services, visit our website, follow us on social media, or contact one of our representatives. We look forward to supporting the development of your projects.

KymaThera

KymaThera combines deep scientific insights with disciplined execution to build best-in-class precision medicines. Its accomplished research team has discovered multiple approved medicines to treat cancer and other serious diseases. Drawing on decades of collective drug discovery experience, KymaThera applies a proprietary framework for strategic structure-based drug design to create differentiated small-molecule therapeutics for better patient outcomes.